Direct Sensing of Superoxide and Its Relatives Reactive Oxygen and Nitrogen Species in Phosphate Buffers during Cold Atmospheric Plasmas Exposures

Arc plasma for high-efficiency ionization and scavenging of plasticizers in wrap films

Herein, ambient electric arc ionization mass spectrometry was used to examine 16 plasticizers in various wrap films, demonstrating high sensitivity (detection limit: <0.2 ng/mg) and precision (intra-/inter-day precision: <12 %). The ease of operation helps in the identification of wrap film and plasticizer analysis. In addition, the introduction of a cold arc plasma treatment presents a practical and innovative method for effectively eliminating plasticizers. This innovative strategy has implications for both environmental protection and food safety.

Easy cleaning plus stable activation of glassy carbon electrode surface by oxygen plasma

Glassy carbon (GC) electrodes are widely used in electroanalytical applications especially in bioelectrochemistry. Their use starts with an efficient surface cleaning and activation protocol, mostly based on surface polishing steps. We studied the use of an oxygen plasma exposure of GC electrodes to replace common polishing procedures. The cyclic voltammetry (CV) responses of ferrocyanide and ferrocene-dimethanol were used to compare brand new, surface-polished and plasma-treated GC electrodes. Plasma treatment induces CV responses with improved features, close to theoretical values, as compared to other methods. The plasma effects were quasi-stable over a week when electrodes were stored in water, this being explained by increased surface energy and hydrophilicity. Furthermore, when electroreduction of diazonium was performed on GC electrodes, the surface blockade could be removed by the plasma. Thus, a short oxygen plasma treatment is prone to replace polishing protocols, that display person-dependent efficiency, in most of the experiments with GC electrodes.

Plasma-Derived Nanoclusters for Site-Specific Multimodality Photo/Magnetic Thrombus Theranostics

Traditional thrombolytic therapeutics for vascular blockage are affected by their limited penetration into thrombi, associated off-target side effects, and low bioavailability, leading to insufficient thrombolytic efficacy. It is hypothesized that these limitations can be overcome by the precisely controlled and targeted delivery of thrombolytic therapeutics. A theranostic platform is developed that is biocompatible, fluorescent, magnetic, and well-characterized, with multiple targeting modes. This multimodal theranostic system can be remotely visualized and magnetically guided toward thrombi, noninvasively irradiated by near-infrared (NIR) phototherapies, and remotely activated by actuated magnets for additional mechanical therapy. Magnetic guidance can also improve the penetration of nanomedicines into thrombi. In a mouse model of thrombosis, the thrombosis residues are reduced by ≈80% and with no risk of side effects or of secondary embolization. This strategy not only enables the progression of thrombolysis but also accelerates the lysis rate, thereby facilitating its prospective use in time-critical thrombolytic treatment.

Near-infrared Fluorescent Probes with Long-acting Cyclic Monitoring and Effectively Eliminating Peroxynitrite

Two through-bond energy transfer fluorescent probes with a dihydroxyl naphthyl-pyrenyl conjugated system were synthesized for long-acting cyclic monitoring and eliminating peroxynitrite (ONOO- ). The probes exhibit large Stokes shifts (230 or 280 nm) and the fluorescence at 620 or 652 nm rapidly change in response to continuously variable concentrations of ONOO- under physiological conditions. The probes show good reversibility and can rapidly monitor the concentration changes of ONOO- in real time. In addition, with the additions of the probes, the decomposition of ONOO- is greatly accelerated. Therefore, the probes can effectively eliminate the excess ONOO- as well as sensing it. The biological studies showed that the probes can effectively and reversibly eliminate both exogenous and endogenous ONOO- in-situ as well as sensing its changes in cells, which can help to maintain the normal physiological concentration of ONOO- in organisms. This is the first system that a probe achieves multifunction including real-time detection, long-acting cyclic monitoring and in-situ elimination, thereby maintaining a normal physiological balance for ONOO- .

Opportunities of Electronic and Optical Sensors in Autonomous Medical Plasma Technologies

Low temperature plasma technology is proving to be at the frontier of emerging medical technologies with real potential to overcome escalating healthcare challenges including antimicrobial and anticancer resistance. However, significant improvements in efficacy, safety, and reproducibility of plasma treatments need to be addressed to realize the full clinical potential of the technology. To improve plasma treatments recent research has focused on integrating automated feedback control systems into medical plasma technologies to maintain optimal performance and safety. However, more advanced diagnostic systems are still needed to provide data into feedback control systems with sufficient levels of sensitivity, accuracy, and reproducibility. These diagnostic systems need to be compatible with the biological target and to also not perturb the plasma treatment. This paper reviews the state-of-the-art electronic and optical sensors that might be suitable to address this unmet technological need, and the steps needed to integrate these sensors into autonomous plasma systems. Realizing this technological gap could facilitate the development of next-generation medical plasma technologies with strong potential to yield superior healthcare outcomes.